Jul 2026· International Journal of Clinical Oncology· Vol 31, pp. 1791 - 1819· 0 citations· 245 references
Medicine
TL;DR
Simultaneous targeting of factors regulating CSCs and TME, along with standard of care therapies, proves a better strategy to tackle CSC heterogeneity and their adaptation for metastatic disease.
Cancer stem cells (CSCs) are tumor cell subsets with self-renewal, multilineage differentiation, and tumor-initiating capacity that sustain cancer initiation, progression, metastasis, and relapse. Targeting CSCs therefore represents a promising route to improve the durability of cancer treatment. However, translation o...
Mehreen Ahmed, A. Al-haidari, S. Agarwal et al.· Signal Transduction and Targ...· 0 citations
Introduction: Breast cancer is the most common malignancy in women and a major cause of mortality worldwide. Despite advances in treatment, therapeutic resistance and disease heterogeneity continue to limit the success of existing therapeutic approaches. Therefore, the identification of novel therapeutic targets has be...
Stela Novak, I. Kolarov-Bjelobrk, Marko Marjanovic et al.· Archive of Oncology· 0 citations
This comprehensive review highlights BMBC resistance mechanisms, drawing from preclinical models, clinical studies, and genomic analyses, and highlights the potential for personalized, multi-targeted approaches to improve patient outcomes in BMBC.
Paromita Sarker, Shreyas S. Rao· Biochimica et biophysica act...· 0 citations
Plastic features of BCSCs are summarized, their roles in metastasis and multidrug resistance, microenvironmental regulation and relevant therapeutic targeting strategies are summarized and progress toward subtype-specific combination approaches is indicated.
Mu-Yao Li, Ying Zhou, Xin-Qi Liu et al.· Cancer Advances· 0 citations
This comprehensive review delves into recent advances in modern therapeutic approaches that aim to enhance the efficacy of conventional treatments for rare brain metastases from breast cancer and systematically evaluates emerging strategies such as advanced drug delivery technologies, including nanoparticles (NPs), pol...
Ghazala Muteeb, Aya Y El-Sayed, Mohamed S. AboHoussien et al.· SLAS discovery : advancing l...· 0 citations
Conventional cancer treatments frequently fail because of metastasis, resistance, and serious side effects, making it one of the major causes of death globally. Because of their special qualities, including their capacity to target tumors, modulate the immune system, and promote regeneration, stem cell-based treatments...
Sanchari Bhattacharya, Ishita Debnath, Rajarshi Kasyapi et al.· Research Journal of Pharmacy...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.